Table 2.
Distribution of comorbid conditions or statin use in those without and with elevated hsCRP
| Categorical Variables | hsCRP < 2 mg/L (n = 9) |
hsCRP ≥ 2 mg/L (n = 16) |
P-value |
|---|---|---|---|
| History of chemotherapy | 7 (78%) | 14 (88%) | 0.602 |
| Cancer type (Breast vs. Lung) | 1.000 | ||
| Breast cancer | 4 (44%) | 6 (38%) | |
| Lung cancer | 5 (56%) | 10 (63%) | |
| History of anemia | 1 (11%) | 4 (25%) | 0.621 |
| Obesity | 1 (11%) | 6 (38%) | 0.355 |
| Hypertension | 4 (44%) | 10 (63%) | 0.434 |
| Dyslipidemia | 5 (56%) | 5 (31%) | 0.397 |
| Diabetes Mellitus | 1 (11%) | 5 (31%) | 0.364 |
| Current Smoker | 2 (22%) | 4 (25%) | 1.000 |
| Sedentary Lifestyle | 3 (33%) | 8 (50%) | 0.677 |
| Statin Use | 3 (33%) | 5 (31%) | 1.000 |
| Hormone therapy | 3 (33%) | 4 (25%) | 0.673 |
Legend: Distribution of nominal variables expressed as Yes or No based on medical history and/or medication use. Proportion of those with the presence of categorical comorbid conditions, statin use, or hormone therapy use are reported as number (%). Obesity defined as a body mass index ≥30 kg per meter squared